4//SEC Filing
Peterson Thomas III 4
Accession 0001628908-18-000033
CIK 0001628908other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:31 PM ET
Size
5.4 KB
Accession
0001628908-18-000033
Insider Transaction Report
Form 4
Peterson Thomas III
Chief Operating Officer
Transactions
- Sale
Class A Common Stock
2018-05-14$18.91/sh−10,000$189,100→ 127,868 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
- [F2]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $18.65-$19.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001643498
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:31 PM ET
- Size
- 5.4 KB